Skip to content

ADHD in Germany - Comparison and Integration of Administrative and Epidemiological ADHD Diagnostic Data by Clinical Assessment

ADHD in Germany - Comparison and Integration of Administrative and Epidemiological ADHD Diagnostic Data by Clinical Assessment - INTEGRATE-ADHD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00028866
Enrollment
5000
Registered
2022-11-24
Start date
2021-10-07
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F90

Interventions

Group 1: Parents or legal guardians of children and adolescents aged 0 to 17 years who are insured by the statutory health insurance DAK-Gesundheit and who are registered with an administrative diagno

Sponsors

Robert Koch-Institut, Abteilung für Epidemiologie und Gesundheitsmonitoring
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Years to 17 Years

Inclusion criteria

Inclusion criteria: Child/adolescent aged 0 to 17 years (in 2020); At least one confirmed administrative ADHD diagnosis (ICD-10: F90.0-9, main and/or secondary diagnosis) in 2020 (M1Q criterion); Consent to participate in the study (from the parents, from 14 years on additionally from the children/adolescents themselves)

Exclusion criteria

Exclusion criteria: Leave of health insurance within the year 2020

Design outcomes

Primary

MeasureTime frame
The aim of INTEGRATE-ADHD is to compare, integrate and validate both administrative and epidemiologically reported ADHD diagnostic data by clinical assessment using a guideline-based diagnostic procedure.

Secondary

MeasureTime frame
Further aims are the investigation of health care (utilization of medical and therapeutic services), quality of care and well-being (KIDSCREEN-27) among children and adolescents with an administrative ADHD diagnosis as well as their families and to conduct health economic analyses (in particular on direct and indirect costs).

Countries

Germany

Contacts

Public ContactRobert Schlack

Robert Koch-Institut, Abteilung für Epidemiologie und Gesundheitsmonitoring

schlackr@rki.de+49 30 18754 3749

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026